Pharma Journalist -

SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks’ time on April 27th and 28th,…
Read More...

Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia Pacific markets,…
Read More...

Shenzhen Pregene Biopharma, a clinical-stage biopharmaceutical company engaged in discovering, developing, manufacturing and commercializes innovative medicines and CellPoint, a cell…
Read More...

BeiGene, Ltd. a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide,…
Read More...

The RNA Therapeutic Modalities Team sat down with Dyne Therapeutics, Head of Neuromuscular Research, Stefano Zanotti to find out more about the research he’s undertaking, as well as his…
Read More...

Roche announced new OCREVUS (ocrelizumab) data that show its benefit on disease progression and cognitive outcomes in primary progressive multiple sclerosis (PPMS) and secondary…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and has granted Priority Review for…
Read More...

CanSino Biologics Inc. announced that the National Medical Products Administration of China granted approval for the clinical trial application of its COVID-19 mRNA vaccine in China.…
Read More...

SELLAS Life Sciences Group, Inc. a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, and GenFleet…
Read More...

Opioid use disorder is a serious public health issue in the United States and throughout the world. The Centers for Disease Control and Prevention estimates that the total "economic…
Read More...